European Leukemia Trial Registry
Trial: ALL GMALL SCT Elderly

More Details
Title Dose-reduced Conditioning before allogeneic stemcelltransplantation in elderly patients
Scientific Title A Open phase II study to investitage feasibility, safety and efficacy of dose-reduced stem-cell-transplantation (SCT) in elderly patients (biological age > 55 Jahren) with high-, or highly-risk acute lymphoblastic leukemia (ALL)
Short Title ALL GMALL SCT Elderly
Trialgroup GMALL
Type of Trial multicentric
Disease Acute lymphoblastic leukemia(ALL) Stem cell transplantation
Stem cell transplantation(SCT) ALL
Age > 55 years
Status No longer recruiting
Start of Recruitment 30.05.2006
Leader Ottmann, Prof. Dr., Oliver
Contactperson

Study Physician
Stelljes, Prof. Dr. med., Matthias
Tel: +49 (0)251 8352825
Fax: +49 (0)251 8352838
Email: stelljes@uni-muenster.de

Study Physician
Ottmann, Prof. Dr., Oliver
Tel: +49 (0)69 6301 87070
Fax: +49 (0)69 6301 4170
Email: ottmann@em.uni-frankfurt.de

Study Physician
Kiehl, Prof. Dr. med., Michael
Tel: +49 (0)335 548-4600/4603
Email: innere@klinikumffo.de

Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
created 27.06.2006 Anja Hellenbrecht
changed 14.09.2015 Zena Krüger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org